These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1327806)

  • 1. Dextrorotatory opioids and phencyclidine exert anticonvulsant action in prepiriform cortex.
    Roth JE; Zhang G; Murray TF; Franklin PH
    Eur J Pharmacol; 1992 May; 215(2-3):293-6. PubMed ID: 1327806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands.
    Aram JA; Martin D; Tomczyk M; Zeman S; Millar J; Pohler G; Lodge D
    J Pharmacol Exp Ther; 1989 Jan; 248(1):320-8. PubMed ID: 2536430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextrorotatory opioids induce stereotyped behavior in Sprague-Dawley and Dark Agouti rats.
    Ishmael JE; Franklin PH; Murray TF
    Psychopharmacology (Berl); 1998 Nov; 140(2):206-16. PubMed ID: 9860112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of dextrorotatory opioids with phencyclidine recognition sites in rat brain membranes.
    Murray TF; Leid ME
    Life Sci; 1984 May; 34(20):1899-911. PubMed ID: 6328147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sigma receptor ligand 1,3-di(2-tolyl)guanidine is anticonvulsant in the rat prepiriform cortex.
    Roth JE; Franklin PH; Murray TF
    Eur J Pharmacol; 1993 May; 236(2):327-31. PubMed ID: 8319759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan.
    Chou YC; Liao JF; Chang WY; Lin MF; Chen CF
    Brain Res; 1999 Mar; 821(2):516-9. PubMed ID: 10064839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in anticonvulsant potency and adverse effects between dextromethorphan and dextrorphan in amygdala-kindled and non-kindled rats.
    Löscher W; Hönack D
    Eur J Pharmacol; 1993 Jul; 238(2-3):191-200. PubMed ID: 8405092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phencyclidine receptor ligands attenuate cortical neuronal injury after N-methyl-D-aspartate exposure or hypoxia.
    Goldberg MP; Viseskul V; Choi DW
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1081-7. PubMed ID: 2838603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/sigma-receptor.
    Sircar R; Rappaport M; Nichtenhauser R; Zukin SR
    Brain Res; 1987 Dec; 435(1-2):235-40. PubMed ID: 2827853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-D-aspartate antagonist activity of alpha- and beta-sulfallorphans.
    Shukla VK; Lemaire S
    J Pharmacol Exp Ther; 1997 Jan; 280(1):357-65. PubMed ID: 8996216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.
    Wong EH; Kemp JA; Priestley T; Knight AR; Woodruff GN; Iversen LL
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7104-8. PubMed ID: 3529096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats: comparison with CPPene.
    De Sarro GB; De Sarro A
    Neuropharmacology; 1993 Jan; 32(1):51-8. PubMed ID: 8094234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of various tonic convulsions in mice by dextrorphan and dizocilpine.
    Akaike N; Himori N
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):652-7. PubMed ID: 7689706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.
    Hiramatsu M; Cho AK; Nabeshima T
    Eur J Pharmacol; 1989 Aug; 166(3):359-66. PubMed ID: 2553433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception.
    DeLander GE; Wahl JJ
    Eur J Pharmacol; 1989 Jan; 159(2):149-56. PubMed ID: 2468511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phencyclidine-like discriminative stimulus properties of MK-801 in rats.
    Willetts J; Balster RL
    Eur J Pharmacol; 1988 Jan; 146(1):167-9. PubMed ID: 3280331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal phencyclidine treatment differentially regulates N-methyl-D-aspartate receptor subunit mRNA expression in developing rat cerebral cortex.
    Sircar R; Follesa P; Ticku MK
    Brain Res Mol Brain Res; 1996 Sep; 40(2):214-20. PubMed ID: 8872305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats.
    Marquis KL; Paquette NC; Gussio RP; Moreton JE
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1104-12. PubMed ID: 2557412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the anticonvulsant effects of competitive and non-competitive antagonists of the N-methyl-D-aspartate receptor.
    Nevins ME; Arnolde SM
    Brain Res; 1989 Nov; 503(1):1-4. PubMed ID: 2558775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic effects of phencyclidine-like drugs in rhesus monkeys.
    France CP; Snyder AM; Woods JH
    J Pharmacol Exp Ther; 1989 Jul; 250(1):197-201. PubMed ID: 2501476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.